Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals
暂无分享,去创建一个
[1] M. Stolar. National survey of hospital pharmaceutical services--1985. , 1983, American journal of hospital pharmacy.
[2] Martin Neil Baily,et al. Research and Development Costs and Returns: The U.S. Pharmaceutical Industry , 1972, Journal of Political Economy.
[3] K. Leffler,et al. Persuasion or Information? The Economics of Prescription Drug Advertising , 1981, The Journal of Law and Economics.
[4] A. J. Swartz. Drug product selection. , 1977, American journal of hospital pharmacy.
[5] W. S. Comanor,et al. The political economy of the pharmaceutical industry. , 1986, Journal of economic literature.
[6] Randall S. Brown,et al. Estimating Advantages to Large-Scale Advertising , 1978 .
[7] R. Caves. INFORMATION STRUCTURES OF PRODUCT MARKETS , 1986 .
[8] D Schwartzman. "Innovation in the Pharmaceutical Industry". , 1978, British medical journal.
[9] D. Gaskins,et al. Dynamic limit pricing: Optimal pricing under threat of entry , 1971 .
[10] R. Steiner,et al. Generic Substitution and Prescription Prices: Economic Effects of State Drug Product Selection Laws , 1985 .
[11] R. N. Spivey,et al. Effect of the Drug Price Competition Act on Market Exclusivity of New Drugs: A Simulation , 1986 .
[12] L. Telser,et al. The Theory of Supply with Applications to the Ethical Pharmaceutical Industry , 1975, The Journal of Law and Economics.
[13] F. Tapon,et al. Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry. , 1985, Journal of health economics.
[14] Joseph Shaanan,et al. Stochastic-Dynamic Limiting Pricing: An Empirical Test , 1982 .
[15] C. Fornell,et al. Sources of Market Pioneer Advantages in Consumer Goods Industries , 1985 .
[16] M. Stolar. National survey of hospital pharmaceutical services--1982. , 1983, American journal of hospital pharmacy.
[17] R. Schmalensee. Product Differentiation Advantages of Pioneering Brands , 1980 .
[18] W. Reekie. Price and Quality Competition in the United States Drug Industry , 1978 .
[19] D. Clarke. Econometric Measurement of the Duration of Advertising Effect on Sales , 1976 .
[20] H. Grabowski,et al. Substitution laws and innovation in the pharmaceutical industry. , 1979 .
[21] M. Statman,et al. The effect of patent expiration on the market position of drugs , 1981 .
[22] H. Grabowski,et al. Longer Patents for Lower Imitation Barriers: The 1984 Drug Act , 1986 .
[23] R. Dorfman,et al. Optimal Advertising and Optimal Quality , 1976 .